Copyright
©The Author(s) 2021.
World J Gastroenterol. Jul 14, 2021; 27(26): 4221-4235
Published online Jul 14, 2021. doi: 10.3748/wjg.v27.i26.4221
Published online Jul 14, 2021. doi: 10.3748/wjg.v27.i26.4221
Figure 6 Ubiquitin-specific protease 15 silencing inhibits tumor growth in vivo.
A: Cervical dislocation was used to sacrifice nude mice on day 29 and representative images of xenograft mouse samples were obtained (n = 6); B: Tumor volume was measured every 3 d and a growth curve was drawn; C: Tumor weight was measured when mice were sacrificed; D: Western blotting detected the protein expression of ubiquitin-specific protease 15, β-catenin, c-Myc, and cyclin D1 in tumor samples of two groups. bP < 0.01, data are expressed as the mean ± standard error of the mean. USP15: Ubiquitin-specific protease 15.
- Citation: Zhong M, Zhou L, Fang Z, Yao YY, Zou JP, Xiong JP, Xiang XJ, Deng J. Ubiquitin-specific protease 15 contributes to gastric cancer progression by regulating the Wnt/β-catenin signaling pathway. World J Gastroenterol 2021; 27(26): 4221-4235
- URL: https://www.wjgnet.com/1007-9327/full/v27/i26/4221.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i26.4221